Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress

References

• Kültz D. Molecular and evolutionary basis of the cellular stress response. Ann Rev Physiol. 2005; 67: 225–57.
   PubMed Web of Science ®Google Scholar
• Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. Int J Cell Biol. 2010; 2010: 214074. 10.1155/2010/214074.
   PubMedGoogle Scholar
• Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res. 2011; 1: 98–110.
   PubMed Web of Science ®Google Scholar
• De Maio A. Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. Cell Stress Chaperones. 2011; 16: 235–49.
   PubMed Web of Science ®Google Scholar
• Policastro LL, Ibañez IL, Notcovich C, Duran HA, Podhajcer OL. The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive Oxygen species-targeted gene therapy. Antioxid Redox Signal. Ahead of print 10.1089/ars.2011.4367.
   Web of Science ®Google Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1989; 8: 98–101.
   PubMed Web of Science ®Google Scholar
• Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011; 17: 1359–70.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006; 6: 392–401.
   PubMed Web of Science ®Google Scholar
• de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006; 6: 24–37.
   PubMed Web of Science ®Google Scholar
• Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012; 196: 395–406.
   PubMed Web of Science ®Google Scholar
• Lorger M. Tumor microenvironment in the brain. Cancers. 2012; 4: 218–43. 10.3390/cancers4010218.
   PubMedGoogle Scholar
• Gillies RJ, Verduzco D, Gatenby RA. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer. 2012; 12: 487–93.
   PubMed Web of Science ®Google Scholar
• Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011; 11: 393–410.
   PubMed Web of Science ®Google Scholar
• Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008; 8: 967–75.
   PubMed Web of Science ®Google Scholar
• Chiche J, Brahimi-Horn MC, Pouysségur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med. 2010; 14: 771–94.
   PubMed Web of Science ®Google Scholar
• McCarty MF, Whitaker J. Manipulating tumor acidification as a cancer treatment strategy. Altern Med Rev. 2010; 15: 264–72.
   PubMed Web of Science ®Google Scholar
• Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, etal. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009; 325: 1555–9.
   PubMed Web of Science ®Google Scholar
• Fiaschi T, Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. Int J Cell Biol. 2012; 2012: 762825. 10.1155/2012/762825.
   PubMedGoogle Scholar
• Shieh AC. Biomechanical forces shape the tumor microenvironment. Ann Biomed Eng. 2011; 39: 1379–89.
   PubMed Web of Science ®Google Scholar
• Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011; 29: 235–71.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006; 6: 715–27.
   PubMed Web of Science ®Google Scholar
• Wind NS, Holen I. Multidrug resistance in breast cancer: from in vitro models to clinical studies. Int J Breast Cancer. 2011; 2011: 967419. 10.4061/2011/967419.
   PubMedGoogle Scholar
• Castells M, Thibault B, Delord JP, Couderc B. Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death. Int J Mol Sci. 2012; 13: 9545–71. 10.3390/ijms13089545.
   PubMed Web of Science ®Google Scholar
• Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012; 72: 4875–82.
   PubMed Web of Science ®Google Scholar
• D'Asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J. Oncogenic extracellular vesicles in brain tumor progression. Front Physiol. 2012; 3: 294. 10.3389/fphys.2012.00294.
   Web of Science ®Google Scholar
• van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R. Cell-derived microvesicles and cancer. Neth J Med. 2009; 67: 266–73.
   PubMed Web of Science ®Google Scholar
• Friend C, Marovitz W, Henie G, Henie W, Tsuei D, Hirschhorn K. Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res. 1978; 38: 2581–91.
   PubMed Web of Science ®Google Scholar
• Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, etal. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother. 2010; 59: 841–50.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110: 13–21.
   PubMed Web of Science ®Google Scholar
• Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999; 94: 3791–99.
   PubMed Web of Science ®Google Scholar
• Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, etal. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996; 183: 1161–72.
   PubMed Web of Science ®Google Scholar
• Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9: 581–93.
   PubMed Web of Science ®Google Scholar
• Savina A, Fader CM, Damiani MT, Colombo MI. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic. 2005; 6: 131–43.
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, etal. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010; 12: 19–30.
   PubMed Web of Science ®Google Scholar
• Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, etal. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010; 189: 223–32.
   PubMed Web of Science ®Google Scholar
• Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006; 66: 4795–801.
   PubMed Web of Science ®Google Scholar
• Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, etal. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319: 1244–7.
   PubMed Web of Science ®Google Scholar
• Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, etal. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012; 14: 677–85.
   PubMed Web of Science ®Google Scholar
• Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol. 2006; 172: 923–35.
   PubMed Web of Science ®Google Scholar
• Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, Cheng Y, etal. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic. 2010; 11: 110–22.
   PubMed Web of Science ®Google Scholar
• Fang Y, Wu N, Gan X, Yan W, Morrell JC, Gould SJ. Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol. 2007; 5: e158. 10.1371/journal.pbio.0050158.
   PubMed Web of Science ®Google Scholar
• Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, etal. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009; 19: 1875–85.
   PubMed Web of Science ®Google Scholar
• Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, etal. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun. 2011; 2: 180. 10.1038/ncomms1180.
   PubMed Web of Science ®Google Scholar
• Guescini M, Genedani S, Stocchi V, Agnati LF. Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm. 2010; 117: 1–4.
   PubMed Web of Science ®Google Scholar
• Guescini M, Guidolin D, Vallorani L, Casadei L, Gioacchini AM, Tibollo P, etal. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res. 2010; 316: 1977–84.
   PubMed Web of Science ®Google Scholar
• Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, etal. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002; 360: 295–305.
   PubMed Web of Science ®Google Scholar
• Svensson KJ, Kucharzewska P, Christianson HC, Sköld S, Löfstedt T, Johansson MC, etal. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A. 2011; 108: 13147–52.
   PubMed Web of Science ®Google Scholar
• Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, etal. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011; 71: 5346–56.
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, etal. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008; 10: 619–24.
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A. 2009; 106: 3794–99.
   PubMed Web of Science ®Google Scholar
• Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, etal. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10: 1470–6.
   PubMed Web of Science ®Google Scholar
• Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, etal. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia. 2006; 8: 96–103.
   PubMed Web of Science ®Google Scholar
• Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD, etal. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004; 104: 3257–66.
   PubMed Web of Science ®Google Scholar
• Segura E, Guérin C, Hogg N, Amigorena S, Théry C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol. 2007; 179: 1489–96.
   PubMed Web of Science ®Google Scholar
• Véron P, Segura E, Sugano G, Amigorena S, Théry C. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis. 2005; 35: 81–8.
   Web of Science ®Google Scholar
• Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004; 18: 977–9.
   PubMed Web of Science ®Google Scholar
• Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, etal. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18: 883–91.
   PubMed Web of Science ®Google Scholar
• Wysoczynski M, Ratajczak MZ. Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int J Cancer. 2009; 125: 1595–603.
   PubMed Web of Science ®Google Scholar
• Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, etal. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev. 2012; 21: 3289–97.
   PubMed Web of Science ®Google Scholar
• King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012; 12: 421. 10.1186/1471-2407-12-421.
   PubMed Web of Science ®Google Scholar
• Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, etal. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009; 284: 34211–22.
   PubMed Web of Science ®Google Scholar
• Eldh M, Ekström K, Valadi H, Sjöstrand M, Olsson B, Jernås M, etal. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One. 2010; 5: e15353. 10.1371/journal.pone.0015353.
   PubMed Web of Science ®Google Scholar
• Hedlund M, Nagaeva O, Kargl D, Baranov V, Mincheva-Nilsson L. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One. 2011; 6: e16899. 10.1371/journal.pone.0016899.
   PubMed Web of Science ®Google Scholar
• Zhan R, Leng X, Liu X, Wang X, Gong J, Yan L, etal. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. Biochem Biophys Res Commun. 2009; 387: 229–33.
   PubMed Web of Science ®Google Scholar
• Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci. 2005; 118: 3631–8.
   PubMed Web of Science ®Google Scholar
• Chen T, Guo J, Yang M, Zhu X, Cao X. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol. 2011; 186: 2219–28.
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, etal. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 1996; 88: 3456–64.
   PubMed Web of Science ®Google Scholar
• Lv LH, Wan YL, Lin Y, Zhang W, Yang M, Li GL, etal. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem. 2012; 287: 15874–85.
   PubMed Web of Science ®Google Scholar
• Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, etal. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 2008; 15: 1723–33.
   PubMed Web of Science ®Google Scholar
• Nikolova-Karakashian MN, Rozenova KA. Ceramide in stress response. Adv Exp Med Biol. 2010; 688: 86–108.
   PubMed Web of Science ®Google Scholar
• Sawada M, Nakashima S, Kiyono T, Nakagawa M, Yamada J, Yamakawa H, etal. p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene. 2001; 20: 1368–78.
   Web of Science ®Google Scholar
• Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, etal. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 2005; 105: 1734–41.
   PubMed Web of Science ®Google Scholar
• Di Vizio D, Kim J, Hager MH, Morello M, Yang W, Lafargue CJ, etal. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 2009; 69: 5601–9.
   PubMed Web of Science ®Google Scholar
• Wang Y, Roche O, Xu C, Moriyama EH, Heir P, Chung J, etal. Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A. 2012; 109: 4892–7.
   PubMed Web of Science ®Google Scholar
• MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity. 2001; 15: 825–35.
   PubMed Web of Science ®Google Scholar
• Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, etal. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 2003; 63: 5573–81.
   PubMed Web of Science ®Google Scholar
• Giusti I, D'Ascenzo S, Millimaggi D, Taraboletti G, Carta G, Franceschini N, etal. Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia. 2008; 10: 481–8.
   PubMed Web of Science ®Google Scholar
• Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, etal. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009; 23: 1541–57.
   PubMed Web of Science ®Google Scholar
• Choi DS, Choi DY, Hong BS, Jang SC, Kim DK, Lee J, etal. Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J Extracellular Vesicles. 2012; 1 18704, doi: http://dx.doi.org/10.3402/jev.v1i0.18704.
   Google Scholar
• Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654–9.
   PubMed Web of Science ®Google Scholar
• Carayon K, Chaoui K, Ronzier E, Lazar I, Bertrand-Michel J, Roques V, etal. Proteolipidic composition of exosomes changes during reticulocyte maturation. J Biol Chem. 2011; 286: 34426–39.
   Web of Science ®Google Scholar
• Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, etal. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A. 2011; 108: 15336–41.
   PubMed Web of Science ®Google Scholar
• Khan S, Jutzy JM, Aspe JR, McGregor DW, Neidigh JW, Wall NR. Survivin is released from cancer cells via exosomes. Apoptosis. 2011; 16: 1–12.
   PubMed Web of Science ®Google Scholar
• Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, etal. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. 2010; 9: 1085–99.
   PubMed Web of Science ®Google Scholar
• Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, etal. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012; 14: 249–56.
   PubMed Web of Science ®Google Scholar
• de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, etal. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracellular Vesicles. 2012; 1 18396, doi: http://dx.doi.org/10.3402/jev.v1i0.18396.
   Google Scholar
• Logozzi M, De Milito A, Lugini L, Borghi M, Calabrò L, Spada M, etal. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009; 4: e5219. 10.1371/journal.pone.0005219.
   PubMed Web of Science ®Google Scholar
• Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, etal. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012; 18: 1835–40.
   PubMed Web of Science ®Google Scholar
• Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B, etal. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer. 2012; 106: 768–74.
   PubMed Web of Science ®Google Scholar
• Yokota N, Koizume S, Miyagi E, Hirahara F, Nakamura Y, Kikuchi K, etal. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer. 2009; 101: 2023–9.
   Web of Science ®Google Scholar
• van den Berg YW, Osanto S, Reitsma PH, Versteeg HH. The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood. 2012; 119: 924–32.
   PubMed Web of Science ®Google Scholar
• McCormick R, Buffa FM, Ragoussis J, Harris AL. The role of hypoxia regulated microRNAs in cancer. Curr Top Microbiol Immunol. 2010; 345: 47–70.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang ZH, Kong J, Yang MY, Jiang GH, Wang XP, etal. Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress. Mol Med. 2012; 18: 159–66.
   Web of Science ®Google Scholar
• Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, etal. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature. 2011; 475: 226–30.
   PubMed Web of Science ®Google Scholar
• Whitlow MB, Klein LM. Response of SCC-12F, a human squamous cell carcinoma cell line, to complement attack. J Invest Dermatol. 1997; 109: 39–45.
   Web of Science ®Google Scholar
• Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, etal. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med. 2002; 195: 1303–16.
   PubMed Web of Science ®Google Scholar
• Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, etal. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis. 2005; 35: 169–73.
   PubMed Web of Science ®Google Scholar
• Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007; 67: 7458–66.
   PubMed Web of Science ®Google Scholar
• Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One. 2010; 5: e11469. 10.1371/journal.pone.0011469.
   PubMed Web of Science ®Google Scholar
• Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis. 2005; 34: 206–13.
   PubMed Web of Science ®Google Scholar
• Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, etal. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006; 66: 9290–8.
   PubMed Web of Science ®Google Scholar
• Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, etal. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010; 120: 457–71.
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, etal. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005; 113: 752–60.
   PubMed Web of Science ®Google Scholar
• Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003; 63: 4331–7.
   PubMed Web of Science ®Google Scholar
• Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W, etal. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005; 4: 1595–604.
   PubMed Web of Science ®Google Scholar
• Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, etal. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol. 2012; 227: 658–67.
   PubMed Web of Science ®Google Scholar
• Rzeszowska-Wolny J, Przybyszewski WM, Widel M. Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy. Eur J Pharmacol. 2009; 625: 156–64.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Hayashi S, Hatashita M, Ohnishi K, Shioura H, Ohtsubo T, etal. Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiat Res. 2001; 155: 387–96.
   PubMed Web of Science ®Google Scholar
• Dickey JS, Baird BJ, Redon CE, Sokolov MV, Sedelnikova OA, Bonner WM. Intercellular communication of cellular stress monitored by gamma-H2AX induction. Carcinogenesis. 2009; 30: 1686–95.
   PubMed Web of Science ®Google Scholar
• Hei TK, Zhou H, Chai Y, Ponnaiya B, Ivanov VN. Radiation induced non-targeted response: mechanism and potential clinical implications. Curr Mol Pharmacol. 2011; 4: 96–105.
   PubMedGoogle Scholar